Look behind the lecture: COVID-19 – an opportunity to demonstrate the value of patient-reported outcomes in infectious diseases?

Written by The Evidence Base

In this feature, following his participation in the COVID-19-dedicated plenary session that launched the 2020 Virtual Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (18–20 May), John Powers (George Washington University School of Medicine, DC, USA) discusses the importance of measuring patient-reported outcomes in infectious diseases. Please could you introduce yourself? I am a Professor of clinical medicine at the George Washington University School of Medicine (DC, USA), an internal medicine and infectious diseases physician and a clinical researcher/investigator. I am also a Co-Chair on the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR; NJ, USA) Task...

To view the full article, please register now for access

It's completely free